Showing results (31-40 of 273) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|January 2, 1994
Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumorsC Welter, B Theisinger, M C Rio, et al.
Cancer Letters|June 30, 1990
The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell linesC Welter, W Henn, B Theisinger, et al.
Genomics|August 1, 1991
Large-scale physical mapping within the region 22q12.3-13.1 in meningiomaR Herzog, E Gottert, W Henn, et al.
The Journal of Pathology|July 1, 1992
A two-colour technique for chromosome in situ hybridization in tissue sectionsS Lutz, C Welter, K D Zang, et al.
Genes, Chromosomes & Cancer|March 1, 1993
Telomeric associations and loss of telomeric DNA repeats in renal tumorsK Holzmann, N Blin, C Welter, et al.
Oncology|November 1, 1993
Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significanceN Blin, I Kardaś, C Welter, et al.
Anticancer Research|November 1, 1988
Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastomaT Pietsch, E Göttert, E Meese, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinomaB Theisinger, C Welter, G Seitz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1992
Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinomaC Welter, B Theisinger, G Seitz, et al.
Cancer|September 1, 1993
Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinomaI Kardaś, G Seitz, J Limon, et al.
Pageof 28